Skip to main content
Premium Trial:

Request an Annual Quote

FDA Clears Nanosphere Test for Gram-positive Bacteria

NEW YORK (GenomeWeb News) – Nanosphere today said that it has received de novo clearance from the US Food and Drug Administration to market its Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) on its Verigene System.

The test detects the genus and species for a broad panel of clinically significant gram-positive bacteria, as well as several markers of antimicrobial resistance, including the mecA, vanA, and vanB genes, which confer resistance to methicillin/oxacillin and vancomycin, Nanosphere said. It added that the test can identify bacterial and antimicrobial resistance genes from gram-positive blood culture bottles within two-and-a-half hours, compared to the two to three days required by current microbiological methods.

The sample-to-result BC-GP test automates bacterial DNA extraction and target detection on the Verigene system.

"With the BC-GP test, patients suspected of deadly infections can now get a first-ever diagnostic tool for detecting disease-causing bacteria while simultaneously determining antibiotic resistance within the critical timeframe for making and adjusting initial treatment," Nanosphere CEO William Moffitt said in a statement.

The Northbrook, Ill.-based company added that it is developing a test for gram-negative blood cultures that will detect genus, species, and resistance on an automated platform. It also plans to submit a test for C. difficile and a panel of enteric bacterial and viral pathogens for FDA clearance this year.

Shares of Nanosphere closed up 21 percent at $2.32 in Wednesday trade on the Nasdaq.

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.